Enterprise Value
463.4M
Cash
260.5M
Avg Qtr Burn
-16.81M
Short % of Float
3.40%
Insider Ownership
11.52%
Institutional Own.
72.45%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HIL-214 Details Norovirus | Phase 2b Data readout |